Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that seeks to provide investment results corresponding to the price and yield performance, before fees and expenses, of the IBD Breakout Opportunities Index. The fund employs a rules-based strategy focused on identifying U.S.-listed equities exhibiting breakout momentum patterns as defined by Investor's Business Daily's proprietary methodology; it invests at least 80% of its net assets in securities comprising the index, which targets small- and mid-cap growth stocks with strong relative price strength, high earnings growth, and institutional sponsorship. BOUT offers investors exposure to dynamic growth opportunities through daily portfolio adjustments to track the index, which rebalances weekly and emphasizes companies showing new highs, volume surges, and technical breakouts. Launched in April 2019 and domiciled in the United States, the ETF operates primarily in the U.S. equity markets with a focus on technology, consumer discretionary, and healthcare sectors serving institutional and retail investors seeking momentum-driven returns. In recent developments, Innovator Capital Management, the fund's sponsor, expanded its suite of defined outcome and buffer ETFs in 2024, while BOUT benefited from enhanced liquidity provisions and a strategic alliance with Investor's Business Daily to refine index construction amid rising interest in tactical growth strategies.